-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Barrett Esophagus are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Barrett Esophagus.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa.
El-Rifai W, Frierson HF, Moskaluk CA, Harper JC, Petroni GR, Bissonette EA, Jones DR, Knuutila S, Powell SM
(2001) Gastroenterology 121: 592-8 - Barrett's esophagus surveillance: time to rethink if one size fits all?
Vaezi MF, Kahrilas PJ
(2013) Gastroenterology 145: 503-5 - Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R, Goldblum J, Gress F, Ilson DH, Inadomi JM, Kuipers EJ, Lynch JP, McKeon F, Metz D, Pasricha PJ, Pech O, Peek R, Peters JH, Repici A, Seewald S, Shaheen NJ, Souza RF, Spechler SJ, Vennalaganti P, Wang K
(2015) Gastroenterology 149: 1599-606 - Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.
Abrams JA, Appelman HD, Beer DG, Berry LD, Chak A, Falk GW, Fitzgerald RC, Ginsberg GG, Grady WM, Joshi BP, Lynch JP, Markowitz S, Richmond ES, Rustgi AK, Seibel EJ, Shaheen NJ, Shyr Y, Umar A, Wang KK, Wang TC, Wang TD, Yassin R
(2014) Gastroenterology 146: 1586-90 - Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.
Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z
(2009) Gastroenterology 137: 588-97 - DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.
Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R, El-Rifai W
(2009) Gut 58: 5-15 - Tissue culture of epithelium derived from Barrett's oesophagus.
Washington K, Gottfried MR, Telen MJ
(1994) Gut 35: 879-83 - Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells.
Peng D, Belkhiri A, Hu T, Chaturvedi R, Asim M, Wilson KT, Zaika A, El-Rifai W
(2012) Gut 61: 1250-60 - A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.
Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ
(2009) Cancer Res 69: 4112-5 - Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
Wilson KT, Fu S, Ramanujam KS, Meltzer SJ
(1998) Cancer Res 58: 2929-34 - Activation of Wnt signalling promotes development of dysplasia in Barrett's oesophagus.
Moyes LH, McEwan H, Radulescu S, Pawlikowski J, Lamm CG, Nixon C, Sansom OJ, Going JJ, Fullarton GM, Adams PD
(2012) J Pathol 228: 99-112 - Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus.
Yachimski P, Maqbool S, Bhat YM, Richter JE, Falk GW, Vaezi MF
(2015) Am J Gastroenterol 110: 1143-8 - Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.
Montgomery E, Bronner MP, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Goldblum JR
(2002) Am J Gastroenterol 97: 27-31 - Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM
(2002) Am J Gastroenterol 97: 302-11 - Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus.
Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C
(2015) Clin Gastroenterol Hepatol 13: 84-90 - Modifiable Risk Factors for Barrett's Esophagus and Esophageal Adenocarcinoma: Still a Shot in the Dark.
Yachimski P
(2016) Clin Gastroenterol Hepatol 14: 773-4 - APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
Hong J, Chen Z, Peng D, Zaika A, Revetta F, Washington MK, Belkhiri A, El-Rifai W
(2016) Oncotarget 7: 16688-702 - Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.
Taylor C, Loomans HA, Le Bras GF, Koumangoye RB, Romero-Morales AI, Quast LL, Zaika AI, El-Rifai W, Andl T, Andl CD
(2015) Oncotarget 6: 34228-44 - Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
Peng D, Sheta EA, Powell SM, Moskaluk CA, Washington K, Goldknopf IL, El-Rifai W
(2008) Int J Cancer 122: 1303-10 - Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia.
Peek RM, Vaezi MF, Falk GW, Goldblum JR, Perez-Perez GI, Richter JE, Blaser MJ
(1999) Int J Cancer 82: 520-4 - Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.
Peng DF, Hu TL, Soutto M, Belkhiri A, El-Rifai W
(2014) Carcinogenesis 35: 1620-8 - Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts.
Bhardwaj V, Horvat A, Korolkova O, Washington MK, El-Rifai W, Dikalov SI, Zaika AI
(2016) Carcinogenesis 37: 1161-1169 - Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D
(1998) Mod Pathol 11: 805-13 - Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K
(2000) Mod Pathol 13: 475-81 - Esophageal cancer.
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G, NCCN Esophageal Cancer Panel
(2008) J Natl Compr Canc Netw 6: 818-49 - Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB, Washington K, Keswani RN
(2011) J Natl Compr Canc Netw 9: 890-9 - DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
Kaz AM, Wong CJ, Luo Y, Virgin JB, Washington MK, Willis JE, Leidner RS, Chak A, Grady WM
(2011) Epigenetics 6: 1403-12 - CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.
Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E
(2005) Am J Surg Pathol 29: 390-9 - Translational research on Barrett's esophagus.
Baruah A, Buttar N, Chandra R, Chen X, Clemons NJ, Compare D, El-Rifai W, Gu J, Houchen CW, Koh SY, Li W, Nardone G, Phillips WA, Sharma A, Singh I, Upton MP, Vega KJ, Wu X
(2014) Ann N Y Acad Sci 1325: 170-86 - Surgery for cancer of the esophagus.
Roth JA, Putnam JB
(1994) Semin Oncol 21: 453-61 - Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus.
Kuester D, El-Rifai W, Peng D, Ruemmele P, Kroeckel I, Peters B, Moskaluk CA, Stolte M, Mönkemüller K, Meyer F, Schulz HU, Hartmann A, Roessner A, Schneider-Stock R
(2009) Cancer Lett 275: 117-26 - Differential gene expression in normal esophagus and Barrett's esophagus.
Wang J, Qin R, Ma Y, Wu H, Peters H, Tyska M, Shaheen NJ, Chen X
(2009) J Gastroenterol 44: 897-911 - Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W
(2013) PLoS One 8: e64463 - Mitochondrial STAT3 contributes to transformation of Barrett's epithelial cells that express oncogenic Ras in a p53-independent fashion.
Yu C, Huo X, Agoston AT, Zhang X, Theiss AL, Cheng E, Zhang Q, Zaika A, Pham TH, Wang DH, Lobie PE, Odze RD, Spechler SJ, Souza RF
(2015) Am J Physiol Gastrointest Liver Physiol 309: G146-61 - Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression.
Razvi MH, Peng D, Dar AA, Powell SM, Frierson HF, Moskaluk CA, Washington K, El-Rifai W
(2007) Genes Chromosomes Cancer 46: 914-28 - Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.
Ayers K, Shi C, Washington K, Yachimski P
(2013) Surg Endosc 27: 2836-40 - Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Dai Q, Cantwell MM, Murray LJ, Zheng W, Anderson LA, Coleman HG, FINBAR study group
(2016) Br J Nutr 115: 342-50 - Activation of NADPH oxidases leads to DNA damage in esophageal cells.
Bhardwaj V, Gokulan RC, Horvat A, Yermalitskaya L, Korolkova O, Washington KM, El-Rifai W, Dikalov SI, Zaika AI
(2017) Sci Rep 7: 9956 - Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus.
Robert ME, Washington MK, Lee JR, Goldenring JR, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart JA, Lamps LW, Lauwers GY, Lewin D, Lazenby AJ, Montgomery E, Crawford JM
(2005) Am J Clin Pathol 124: 519-27 - Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J
(2001) Hum Pathol 32: 379-88
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
